BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 2770867)

  • 1. The allosteric transition of glycogen phosphorylase.
    Barford D; Johnson LN
    Nature; 1989 Aug; 340(6235):609-16. PubMed ID: 2770867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystallographic binding studies on the allosteric inhibitor glucose-6-phosphate to T state glycogen phosphorylase b.
    Johnson LN; Snape P; Martin JL; Acharya KR; Barford D; Oikonomakos NG
    J Mol Biol; 1993 Jul; 232(1):253-67. PubMed ID: 8331662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allosteric inhibition of glycogen phosphorylase a by the potential antidiabetic drug 3-isopropyl 4-(2-chlorophenyl)-1,4-dihydro-1-ethyl-2-methyl-pyridine-3,5,6-tricarbo xylate.
    Oikonomakos NG; Tsitsanou KE; Zographos SE; Skamnaki VT; Goldmann S; Bischoff H
    Protein Sci; 1999 Oct; 8(10):1930-45. PubMed ID: 10548038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ternary complex crystal structures of glycogen phosphorylase with the transition state analogue nojirimycin tetrazole and phosphate in the T and R states.
    Mitchell EP; Withers SG; Ermert P; Vasella AT; Garman EF; Oikonomakos NG; Johnson LN
    Biochemistry; 1996 Jun; 35(23):7341-55. PubMed ID: 8652510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of phosphorylase b conformation by a modified cofactor: crystallographic studies on R-state glycogen phosphorylase reconstituted with pyridoxal 5'-diphosphate.
    Leonidas DD; Oikonomakos NG; Papageorgiou AC; Acharya KR; Barford D; Johnson LN
    Protein Sci; 1992 Sep; 1(9):1112-22. PubMed ID: 1304390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The molecular mechanism for the tetrameric association of glycogen phosphorylase promoted by protein phosphorylation.
    Barford D; Johnson LN
    Protein Sci; 1992 Apr; 1(4):472-93. PubMed ID: 1304350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Refined crystal structure of the phosphorylase-heptulose 2-phosphate-oligosaccharide-AMP complex.
    Johnson LN; Acharya KR; Jordan MD; McLaughlin PJ
    J Mol Biol; 1990 Feb; 211(3):645-61. PubMed ID: 2106586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The binding of 2-deoxy-D-glucose 6-phosphate to glycogen phosphorylase b: kinetic and crystallographic studies.
    Oikonomakos NG; Zographos SE; Johnson LN; Papageorgiou AC; Acharya KR
    J Mol Biol; 1995 Dec; 254(5):900-17. PubMed ID: 7500360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural mechanism for glycogen phosphorylase control by phosphorylation and AMP.
    Barford D; Hu SH; Johnson LN
    J Mol Biol; 1991 Mar; 218(1):233-60. PubMed ID: 1900534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partial activation of muscle phosphorylase by replacement of serine 14 with acidic residues at the site of regulatory phosphorylation.
    Buchbinder JL; Luong CB; Browner MF; Fletterick RJ
    Biochemistry; 1997 Jul; 36(26):8039-44. PubMed ID: 9201951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of human liver glycogen phosphorylase by alteration of the secondary structure and packing of the catalytic core.
    Rath VL; Ammirati M; LeMotte PK; Fennell KF; Mansour MN; Danley DE; Hynes TR; Schulte GK; Wasilko DJ; Pandit J
    Mol Cell; 2000 Jul; 6(1):139-48. PubMed ID: 10949035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toward a mechanism for the allosteric transition of pig kidney fructose-1,6-bisphosphatase.
    Zhang Y; Liang JY; Huang S; Lipscomb WN
    J Mol Biol; 1994 Dec; 244(5):609-24. PubMed ID: 7990142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The crystal structure of Escherichia coli maltodextrin phosphorylase provides an explanation for the activity without control in this basic archetype of a phosphorylase.
    Watson KA; Schinzel R; Palm D; Johnson LN
    EMBO J; 1997 Jan; 16(1):1-14. PubMed ID: 9009262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for an active T-state pig kidney fructose 1,6-bisphosphatase: interface residue Lys-42 is important for allosteric inhibition and AMP cooperativity.
    Lu G; Stec B; Giroux EL; Kantrowitz ER
    Protein Sci; 1996 Nov; 5(11):2333-42. PubMed ID: 8931152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Interaction of muscle glycogen phosphorylase B with methotrexate, folic and folinic acids].
    Klinov SV; Chebotareva NA; Sheĭman BM; Birinberg EM; Kurganov BI
    Bioorg Khim; 1987 Jul; 13(7):908-14. PubMed ID: 3499906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of allosteric control in glycogen phosphorylase.
    Hudson JW; Golding GB; Crerar MM
    J Mol Biol; 1993 Dec; 234(3):700-21. PubMed ID: 8254668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Slow conformational transitions of muscle glycogen phosphorylase b induced by specific ligands.
    Kurganov BI; Schors EI
    Biochem Mol Biol Int; 1994 May; 33(1):65-72. PubMed ID: 8081214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Purification and properties of glycogen phosphorylase isolated from bovine skeletal muscles].
    Skolysheva LK; Shur SA; Vul'fson PL
    Biokhimiia; 1987 Dec; 52(12):1994-2001. PubMed ID: 3129032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of pyridoxal 5'-phosphate in the structure and function of glycogen phosphorylase.
    Hedrick JL
    Adv Biochem Psychopharmacol; 1972; 4():23-37. PubMed ID: 4555930
    [No Abstract]   [Full Text] [Related]  

  • 20. Allosteric communication in dihydrofolate reductase: signaling network and pathways for closed to occluded transition and back.
    Chen J; Dima RI; Thirumalai D
    J Mol Biol; 2007 Nov; 374(1):250-66. PubMed ID: 17916364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.